Consonance Capital Management LP Spring Works Therapeutics, Inc. Transaction History

Consonance Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$53.3 - $75.84 $16.3 Million - $23.2 Million	-305,994 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$62.66 - $88.26 $56 Million - $78.8 Million	-893,345 Reduced 74.49%	305,994 $19.4 Million
Q2 2021 Aug 16, 2021	SELL	$67.45 - $85.63 $138,947 - $176,397	-2,060 Reduced 0.17%	1,199,339 $98.8 Million
Q1 2021 May 17, 2021	BUY	$65.1 - $93.59 $20 Million - $28.8 Million	307,900 Added 34.46%	1,201,399 $88.4 Million
Q4 2020 Feb 16, 2021	BUY	$48.36 - $77.92 $14.1 Million - $22.7 Million	290,767 Added 48.24%	893,499 $64.8 Million
Q3 2020 Nov 16, 2020	BUY	$36.14 - $51.99 $21.8 Million - $31.3 Million	602,732 New	602,732 $28.7 Million

238

69.8M

144K

257K

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.6B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.